In Figure6, we summarize the indirect and direct effects seen by meforminin in this preoperative window study, including a decrease in serum glucose and enhanced lipolysis coupled with inhibition of the mTOR pathway and increased fatty acid oxidation and glycogen synthesis in the endometrial tumor cells themselves. Here, MTOR is linked to endometrium neoplasm.